Veeva-Salesforce split: A catalyst for commercial transformation in life sciences

Life sciences companies can turn a forced choice into a strategic opportunity to revolutionize healthcare professional (HCP) engagement

The Veeva–Salesforce split is forcing a decision for nearly every life sciences company — but it’s also opening the door to something bigger. In this point of view, we explore how this moment can spark a true transformation in HCP engagement, driven by smarter CRM strategy and emerging technologies.